Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Low Dose Vasopressin in Traumatic Shock: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Vasopressin in Traumatic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00420407).
- Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management: Complete Statistical AnalysisIndependent statistical analysis of Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02129608).
- Low Nicotine Cigarettes Plus Electronic Cigarettes: Complete Statistical AnalysisIndependent statistical analysis of Low Nicotine Cigarettes Plus Electronic Cigarettes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04058717).
- Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL): Complete Statistical AnalysisIndependent statistical analysis of Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings – Optimization Phase: Complete Statistical AnalysisIndependent statistical analysis of Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00082355).
- Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00113321).
- Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01874951).
- Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Low-Level Laser Therapy for Prevention of Oral Mucositis: Complete Statistical AnalysisIndependent statistical analysis of Low-Level Laser Therapy for Prevention of Oral Mucositis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02682992).
- Low-Level Laser Therapy for Prevention of Oral Mucositis: Complete Statistical AnalysisIndependent statistical analysis of Low-Level Laser Therapy for Prevention of Oral Mucositis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02723604).
- Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LPB Hip ScopeIndependent statistical analysis of Lumbar Plexus Block for Postoperative Pain Control After Hip Arthroscopy. A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LPS-FluenzIndependent statistical analysis of The Effects of Preceding LPS Administration on the Fluenz-induced Immune Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LRTforDME+PRPIndependent statistical analysis of Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00445003).
- LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- LSPI-2Independent statistical analysis of Phase IIa L-serine Trial for eAD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03062449).
- LT Vaccine Patch Self-Administration Study: Complete Statistical AnalysisIndependent statistical analysis of LT Vaccine Patch Self-Administration Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00565461).
- LTBIIndependent statistical analysis of Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00804713).
- LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04): Complete Statistical AnalysisIndependent statistical analysis of LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation: Complete Statistical AnalysisIndependent statistical analysis of Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration: Complete Statistical AnalysisIndependent statistical analysis of Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Lucica ® Glycated Albumin-L Clinical Program – Pivotal Study: Complete Statistical AnalysisIndependent statistical analysis of Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02489773).
- Lumbar Drain After Endoscopic Surgery of the Skull Base: Complete Statistical AnalysisIndependent statistical analysis of Lumbar Drain After Endoscopic Surgery of the Skull Base: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03163134).
- LUME-Lung 1Complete statistical analysis of LUME-Lung 1, the phase 3 randomized trial of BIBF 1120 plus docetaxel versus placebo plus docetaxel in second-line non-small cell lung cancer, including time-to-event, response, disease-control, quality-of-life, and…
- LUMINIzEIndependent statistical analysis of Feasibility Study on the VERAFEYE System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05931835).
- LUNA 3Independent statistical analysis of Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Lung Cancer Screening Eligibility Assessment: Complete Statistical AnalysisIndependent statistical analysis of Lung Cancer Screening Eligibility Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06133816).
- Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Lurasidone – A 24-week Extension Study of Patients With Bipolar I Depression: Complete Statistical AnalysisIndependent statistical analysis of Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Lurasidone Pediatric Autism Study: Complete Statistical AnalysisIndependent statistical analysis of Lurasidone Pediatric Autism Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01911442).
- Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures: Complete Statistical AnalysisIndependent statistical analysis of LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib: Complete Statistical AnalysisIndependent statistical analysis of LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing…
- LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator’s Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib: Complete Statistical AnalysisIndependent statistical analysis of LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib: primary endpoint…
- LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung: Complete Statistical AnalysisIndependent statistical analysis of LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung: primary endpoint results, effect estimate…
- LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy:…
- LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05780268).
- Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP): Complete Statistical AnalysisIndependent statistical analysis of Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00770991).
- Lyophilized IMVAMUNE® (1×10^8 TCID50) Versus Liquid IMVAMUNE® (1×10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2×10^7 TCID50) Administered Intradermally: Complete Statistical AnalysisIndependent statistical analysis of Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally: primary endpoint results, effect estimate with confidence…
- Lyrica (Pregabalin) Korean Post Marketing Surveillance Study: Complete Statistical AnalysisIndependent statistical analysis of Lyrica (Pregabalin) Korean Post Marketing Surveillance Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01220180).
- LYT-100 in Post-acute COVID-19 Respiratory Disease: Complete Statistical AnalysisIndependent statistical analysis of LYT-100 in Post-acute COVID-19 Respiratory Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04652518).
- M-F0434Independent statistical analysis of Neuropathic Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01263132).
- M-PLACEIndependent statistical analysis of Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- M-RePoRTIndependent statistical analysis of Metformin for Rising PSA Remote Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02376166).
- M032-HSV-1Independent statistical analysis of Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…